Filing Flows › Standard Biotools (LAB) › How it makes money
How Standard Biotools (LAB) makes money
Standard Biotools (LAB) made $19.4M of revenue in the third quarter 2026 (Q3 2026), -0.9% from a year earlier. Product brought in $14.3M (74%); Services and Other Revenue brought in $5.1M (26%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Product | $14.3M | 73.9% | -1% | +4% |
| ↳ Consumables | $8.3M | 43.0% | -11% | -4% |
| ↳ Instruments | $6.0M | 30.9% | +17% | +18% |
| Services and Other Revenue | $5.1M | 26.1% | -10% | -12% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $19.4M | 100.0% |
| Income tax | $27K | 0.1% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $19.4M | -0.9% |
| Q2 2026 | $20.1M | -8% |
| Q1 2026 | $21.1M | +5% |
| Q4 2025 | $23.8M | -4% |
| Q3 2025 | $19.6M | -12% |
| Q2 2025 | $21.8M | -3% |
| Q1 2025 | $40.8M | -10% |
From Standard Biotools' 10-Q filed Nov 3, 2026 (on EDGAR).
Questions
How does Standard Biotools make money?
Standard Biotools (LAB) made $19.4M of revenue in the third quarter 2026 (Q3 2026), -0.9% from a year earlier. Product brought in $14.3M (74%); Services and Other Revenue brought in $5.1M (26%).
What is Standard Biotools' biggest business?
Product: $14.3M in the third quarter 2026, 74% of revenue, +4% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.